First genome-wide association study of latent autoimmune diabetes in adults reveals novel insights linking immune and metabolic diabetes

Academic Article

Abstract

  • ¬© 2018 by the American Diabetes Association. OBJECTIVE Latent autoimmune diabetes in adults (LADA) shares clinical features with both type 1 and type 2 diabetes; however, there is ongoing debate regarding the precise definition of LADA. Understanding its genetic basis is one potential strategy to gain insight into appropriate classification of this diabetes subtype. RESEARCH DESIGN AND METHODS We performed the first genome-wide association study of LADA in case subjects of European ancestry versus population control subjects (n = 2,634 vs. 5,947) and compared against both case subjects with type 1 diabetes (n = 2,454 vs. 968) and type 2 diabetes (n = 2,779 vs. 10,396). RESULTS The leading genetic signals were principally shared with type 1 diabetes, although we observed positive genetic correlations genome-wide with both type 1 and type 2 diabetes. Additionally, we observed a novel independent signal at the known type 1 diabetes locus harboring PFKFB3, encoding a regulator of glycolysis and insulin signaling in type 2 diabetes and inflammation and autophagy in autoimmune disease, as well as an attenuation of key type 1‚Äďassociated HLA haplotype frequencies in LADA, suggesting that these are factors that distinguish childhood-onset type 1 diabetes from adult autoimmune diabetes. CONCLUSIONS Our results support the need for further investigations of the genetic factors that distinguish forms of autoimmune diabetes as well as more precise classification strategies.
  • Authors

    Published In

  • Diabetes Care  Journal
  • Digital Object Identifier (doi)

    Author List

  • Cousminer DL; Ahlqvist E; Mishra R; Andersen MK; Chesi A; Hawa MI; Davis A; Hodge KM; Bradfield JP; Zhou K
  • Start Page

  • 2396
  • End Page

  • 2403
  • Volume

  • 41
  • Issue

  • 11